Source: Research Seminar 2015



Rating:

Share or cite this content

Citations should be made in the following way:
A. Wells. Endpoints in IPF and lung cancer trials: controversies and perspectives. Research Seminar 2015

Member's Comments

No comment yet.

Related content which might interest you: Biomarkers in early-detection of lung cancer: current concepts Source: Virtual Congress 2021 – Biomarkers in early-detection of lung cancer: current concepts Year: 2021 Lung disease induced by newer therapies for lung cancer: an update Source: Annual Congress 2006 - Drug-induced lung injury – new aspects Year: 2006 Common therapeutic approaches in IPF and lung cancer Source: Research Seminar 2015 Year: 2015 Outcomes for COPD pharmacological trials: from lung function to Biomarkers Source: ERS Live 2008 Year: 2008 Outcomes for COPD pharmacological trials: from lung function to Biomarkers Source: Guideline 2008 Year: 2008 Outcomes for COPD pharmacological trials: from lung function to biomarkers Source: Eur Respir J 2008; 31: 416-469 Year: 2008 Questions on the surveillance of COPD: lessons from cancer Source: ISSN=ISSN 1810-6838, ISBN=, page=192 Year: 2005 Enrolment in clinical trials enhances the survival benefit provided to lung cancer patients Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 Biomarkers for non-small cell lung cancer (NSCLC) treatment: examples and unmet needs, a clinical perspective Source: International Congress 2014 – From bench to bedside: biomarkers and biobanking for lung cancer in 2014 Year: 2014 Lung cancer screening in never-smokers: facts and remaining issues Source: Eur Respir J, 56 (5) 2002949; 10.1183/13993003.02949-2020 Year: 2020 Emphysema, COPD and lung cancer screening. Update of an ongoing study Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012 Impact of COPD on prognosis of lung cancer: the prespective of immunotherapy treatment Source: Virtual Congress 2021 – Therapy of lung cancer Year: 2021 Challenges in molecular testing in lung cancer patients with advanced disease Source: International Congress 2016 – Lung cancer: latest developments in screening and patient management Year: 2016 Cardiovascular effects of innovative therapies in lung cancer Source: Eur Respir Monogr 2020; 88: 154-166 Year: 2020 Commentary: The ERS/ESTS clinical guidelines for evaluating fitness for radical treatment for lung cancer Source: Breathe 2008; 6: 141-145 Year: 2009 Lung cancer screening: latest developments and unanswered questions Source: International Congress 2016 – Lung cancer: latest developments in screening and patient management Year: 2016 Milestones in the management of lung cancer Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009 Epidemiology, clinical, imaging and histology aspects of lung cancer in IPF Source: Research Seminar 2015 Year: 2015